Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts Brent Oil Fd Lp Unit
BNO
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
No Data
Piper Sandler Maintains Humacyte(HUMA.US) With Hold Rating, Maintains Target Price $1
Piper Sandler Keeps Their Hold Rating on Humacyte (HUMA)
Humacyte Faces Nasdaq Non-Compliance Warning as Share Price Risks Delisting and Future Capital Constraints
Humacyte's Symvess Trauma Study: Real-World Data Push With Investor Upside
TD Cowen Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $1.25
Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (ANNX), Humacyte (HUMA) and TScan Therapeutics (TCRX)